Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eric Davis

Blood

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Blood|August 4, 2018
HSP110 and MYD88: blame the chaperoneR Eric Davis
Blood|June 12, 2025
Connecting the DOT1L: it's EZH2R Eric Davis
Blood|September 9, 2021
Killing 2 birds with 1 stone in DLBCLR Eric Davis
Blood|October 2, 2004
PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL inductionChun Crowder, Øyvind Dahle, R Eric Davis, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Blood|December 16, 2004
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cellsLiza Ho, R Eric Davis, Béatrice Conne, et al.
Blood|March 13, 2012
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell linesManuela Lemoine, Enrico Derenzini, Daniela Buglio, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Blood|June 9, 2016
Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemiaSujan Piya, Steven M Kornblau, Vivian R Ruvolo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Blood|August 4, 2018
HSP110 and MYD88: blame the chaperoneR Eric Davis
Blood|June 12, 2025
Connecting the DOT1L: it's EZH2R Eric Davis
Blood|September 9, 2021
Killing 2 birds with 1 stone in DLBCLR Eric Davis
Blood|October 2, 2004
PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL inductionChun Crowder, Øyvind Dahle, R Eric Davis, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Blood|December 16, 2004
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cellsLiza Ho, R Eric Davis, Béatrice Conne, et al.
Blood|March 13, 2012
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell linesManuela Lemoine, Enrico Derenzini, Daniela Buglio, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Blood|June 9, 2016
Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemiaSujan Piya, Steven M Kornblau, Vivian R Ruvolo, et al.
Pageof 2